Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Utendahl Capital Partners was a prominent minority-owned investment banking firm founded in 1992 by John Utendahl. Based in New York City, the firm provided a wide array of financial services, including investment banking, asset management, and institutional brokerage. It was historically significant as one of the largest African-American-owned firms on Wall Street and was involved in numerous high-profile corporate underwritings for Fortune 500 companies. The firm effectively ceased its primary operations around 2010 as its founder transitioned to senior leadership roles at global financial institutions like Deutsche Bank and Bank of America. While the firm was not a life sciences company, it was a key player in the financial markets that support various industries, including healthcare and insurance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Utendahl Capital Partners.